1. Bill Weldon - Johnson & Johnson - $29.4M
2. Miles White - Abbott Laboratories - $28.3M
3. Bernard Poussot - Wyeth - $25M
4. Jim Cornelius - Bristol-Myers Squibb - $25M
5. Richard Clark - Merck - $19.9M
6. Robert Parkinson - Baxter International - $16M
7. David Vasella - Novartis - $15.1M
8. Jeffrey Kindler - Pfizer - $14.8M
9. Frank Baldino - Cephalon - $14.5M
10. John Lechleiter - Eli Lilly - $13M
11. Fred Hassan - Schering-Plough $12.9M
12. Robert Coury - Mylan $12.5M
13. Werner Wenning - Bayer - $4.8M
14. David Brennan - AstraZeneca - $4.7M
15. Severin Schwan - Roche - $4.5M
Hat tip: Fierce Pharma
2. Miles White - Abbott Laboratories - $28.3M
3. Bernard Poussot - Wyeth - $25M
4. Jim Cornelius - Bristol-Myers Squibb - $25M
5. Richard Clark - Merck - $19.9M
6. Robert Parkinson - Baxter International - $16M
7. David Vasella - Novartis - $15.1M
8. Jeffrey Kindler - Pfizer - $14.8M
9. Frank Baldino - Cephalon - $14.5M
10. John Lechleiter - Eli Lilly - $13M
11. Fred Hassan - Schering-Plough $12.9M
12. Robert Coury - Mylan $12.5M
13. Werner Wenning - Bayer - $4.8M
14. David Brennan - AstraZeneca - $4.7M
15. Severin Schwan - Roche - $4.5M
Hat tip: Fierce Pharma
No comments:
Post a Comment